Oncogene - Table of Contents alert Volume 33 Issue 38

If you are unable to see the message below, click here to view.

Advertisement Finally! Antibodies you can TRUST. Partnering with epigenetics experts including the BLUEPRINT Epigenome consortium, Diagenode has developed the absolute best epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 33, Issue 38 (September 2014) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines A Q Butt and K H G Mills Oncogene 2014 33: 4623-4631; advance online publication, October 21, 2013; 10.1038/onc.2013.432 Abstract | Full Text Original Articles Top PTEN functions as a melanoma tumor suppressor by promoting host immune response Y Dong, J-AE Richards, R Gupta, P P Aung, A Emley, Y Kluger, S K Dogra, M Mahalingam and N Wajapeyee Oncogene 2014 33: 4632-4642; advance online publication, October 21, 2013; 10.1038/onc.2013.409 Abstract | Full Text HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase C-H Tsai, C-H Teng, Y-T Tu, T-S Cheng, S-R Wu, C-J Ko, H-Y Shyu, S-W Lan, H-P Huang, S-F Tzeng, M D Johnson, C-Y Lin, P-W Hsiao and M-S Lee Oncogene 2014 33: 4643-4652; advance online publication, October 14, 2013; 10.1038/onc.2013.412 Abstract | Full Text HRG-1 enhances cancer cell invasive potential and couples glucose metabolism to cytosolic/extracellular pH gradient regulation by the vacuolar-H+ ATPase F M Fogarty, J O'Keeffe, A Zhadanov, D Papkovsky, V Ayllon and R O'Connor Oncogene 2014 33: 4653-4663; advance online publication, October 21, 2013; 10.1038/onc.2013.403 Abstract | Full Text microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions OPEN H Ouyang, J Gore, S Deitz and M Korc Oncogene 2014 33: 4664-4674; advance online publication, October 7, 2013; 10.1038/onc.2013.405 Abstract | Full Text Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway OPEN I H Lee, M Sohn, H J Lim, S Yoon, H Oh, S Shin, J H Shin, S-H Oh, J Kim, D K Lee, D Y Noh, D S Bae, J K Seong and Y S Bae Oncogene 2014 33: 4675-4684; advance online publication, March 24, 2014; 10.1038/onc.2014.69 Abstract | Full Text The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a OPEN A Sparks, S Dayal, J Das, P Robertson, S Menendez and M K Saville Oncogene 2014 33: 4685-4696; advance online publication, October 14, 2013; 10.1038/onc.2013.413 Abstract | Full Text SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells OPEN R Santini, S Pietrobono, S Pandolfi, V Montagnani, M D'Amico, J Y Penachioni, M C Vinci, L Borgognoni and B Stecca Oncogene 2014 33: 4697-4708; advance online publication, March 31, 2014; 10.1038/onc.2014.71 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.